Crescent Biopharma, Inc.

CBIO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$133,265$152,645$5,614$10,720
Short-Term Investments$0$0$0$0
Receivables$0$0$0$137
Inventory$0$0$0$0
Other Curr. Assets$1,298$1,582$378$235
Total Curr. Assets$134,563$154,227$5,992$11,091
Property Plant & Equip (Net)$2,346$1,800$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,360$1,406$0$0
Total NC Assets$3,706$3,206$0$0
Other Assets$0$0$0$0
Total Assets$138,269$157,433$5,992$11,091
Liabilities
Payables$2,561$1,648$148$1,378
Short-Term Debt$417$211$0$67
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$17,326$14,887$2,469$4,333
Total Curr. Liab.$20,304$16,746$2,617$5,778
LT Debt$1,324$1,433$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,324$1,433$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$67
Total Liabilities$21,628$18,179$2,617$5,778
Equity
Pref Stock$0$4,000$0$0
Common Stock$14$14$65$64
Retained Earnings-$79,412-$54,805-$496,708-$494,364
AOCI$0$0$0$0
Other Equity$196,039$190,045$500,019$499,613
Total Equity$116,641$139,254$3,375$5,314
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$138,269$157,433$5,992$11,091
Net Debt-$131,524-$151,001-$5,614-$10,653
Crescent Biopharma, Inc. (CBIO) Financial Statements & Key Stats | AlphaPilot